Clinical Trial Update: Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC

View source ↗

Summary

The update outlines an ongoing trial evaluating first-line ABCP therapy for advanced SMARCA4-mutated non-small cell lung cancer, with the study not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ABCP Therapy (ABCP)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Non Small Cell Lung Cancer | Status: NOT_YET_RECRUITING